23 November 2015
The Novo Nordisk Foundation donates an additional grant to research at DanStem
DanStem receives the donation based on an application for New Strategic Funding of the Novo Nordisk section of Basic Stem Cell Biology.
To promote Copenhagen as an international beacon of research within biomedicine and biotechnology The Novo Nordisk Foundation has awarded an additional grant of DKK 235 million (€31.4 million) to DanStem to strengthen and expand the center’s activities.
Since 2011 Dan Stem - The Danish Stem Cell Center at the University of Copenhagen has helped provide scientists with the best possible environment to perform cutting-edge basic stem cell research, and translate these promising results into novel therapies for diabetes and cancer.
To build on this success the new grant will allow the center to invest in state-of-the-art technologies related to single cell analysis and bioengineering as well as strengthen existing technology platforms, to take up new research fields, including pancreatic cancer, and to recruit new key personnel.
“This grant will enable us to continue to position the center internationally as a leader in basic and translational stem cell research in the diabetes and cancer areas,” says Professor Henrik Semb, Executive Director of DanStem.
- Novo Nordisk Foundation awards DKK 235 million for stem cell research Press Release, 23 November 2015
- Novo Nordisk Fonden bevilliger 235 million kroner til forskning i stamceller, Pressemeddelelse, 23. november, 2015